The Patent Finder

Universidad Andrés Bello

7 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
May 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 22, 2027
    The maintenance fee for Controlled release system including a gas or volatile encapsulated in a polymeric support and a matrix system, a method of preparing the system, and their use (US 10,449,156) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Modified 1-Methylcyclopropene (1-MCP) Nanobubbles (US 11,957,133) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,879,058Use of Compounds That Selectively Modulate Astrocytic Release of Substances Through Hemichannels of Connexins and Pannexins, Without Influencing Gap Junctions, for the Treatment of Psychiatric Disorders
In force
 · High confidence
In forceHigh confidence
US 10,449,156Controlled release system including a gas or volatile encapsulated in a polymeric support and a matrix system, a method of preparing the system, and their use
In force
 · USPTO record
In forceUSPTO record
US 11,654,167Pharmaceutical Composition Based on Bacteriophages Against F. Nucleatum; Use in the Treatment of Diseases Associated with This Pathogen
In force
 · Medium confidence
In forceMedium confidence
US 11,331,355Pharmaceutical Composition Based on Bacteriophages Against F. Nucleatum; Use in the Treatment of Diseases Associated with This Pathogen
In force
 · High confidence
In forceHigh confidence
US 11,487,253Method for sequential predictive control, first solving a cost function and subsequently a second cost function for two or more control objectives
In force
 · USPTO record
In forceUSPTO record
US 12,576,120Antiproliferative Effect of Agarophyton Chilensis Extract in Prostate Cancer
In force
 · High confidence
In forceHigh confidence
US 11,957,133Modified 1-Methylcyclopropene (1-MCP) Nanobubbles
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited